VBI Vaccines Announces Second Positive DSMB Review in Phase 1/2a Study of VBI-1901 in Recurrent Glioblastoma Patients
pharmaceutical investing VBI Vaccines Announces Dosing of First Patient in Phase 1/2a Clinical Study of VBI-1901
pharmaceutical investing VBI Vaccines Hepatitis B Data Selected as Presidential Poster of Distinction
Fastmarkets Global Lithium, Battery & Critical Materials returns to Las Vegas as the key meeting point for deals, capital and supply chain strategy
Allied Critical Metals Announces Transformative U.S.$40 Million Financing Package to Fast-Track Tungsten Concentrates Production
